BeiGene vs Caris Life Sciences
BeiGene vs Caris Life Sciences, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BeiGene is on 64/100 and Caris Life Sciences on 59/100.
Where each one leads
BeiGene
- our overall score: 64/100 against 59/100
Caris Life Sciences
- funding raised: $700M against $358M
At a glance
| Measure | BeiGene | Caris Life Sciences |
|---|---|---|
| What it is | A global oncology company developing and commercializing innovative cancer treatments. | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2010 | 2008 |
| Headquarters | Cambridge, United States | Irving, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BeiGene | Caris Life Sciences |
|---|---|---|
| Employees | Not published | 1,659 |
| Open roles | 100 | Not published |
| Total funding | $358M | $700M |
| Latest round | Secondary Offering | Series D |
| Valuation | $15B | $7.8B |
| LinkedIn followers | Not published | 77,698 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BeiGene | Caris Life Sciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 59/100 |
| Traction | 40/100 | 60/100 |
| Team | 30/100 | Not published |
| Search visibility | 17/100 | 22/100 |
| Quality | 88/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 68/100 | 63/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BeiGene | Caris Life Sciences |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
| Analytics | Not detected | Google Tag Manager |
BeiGene vs Caris Life Sciences: common questions
Which is better, BeiGene or Caris Life Sciences?
On our 0-100 score BeiGene rates higher (64/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do BeiGene and Caris Life Sciences compare on the numbers?
BeiGene leads on our overall score (64/100 against 59/100). Caris Life Sciences leads on funding raised ($700M against $358M).
Read the full BeiGene review and pricing or the Caris Life Sciences review and pricing. You can also browse other BeiGene alternatives we track.